Renovorx to host second quarter 2025 financial results and business highlights conference call on august 14th at 4:30 p.m. et

Mountain view, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a life sciences company developing innovative targeted oncology therapies and commercializing renovocath®, a novel, fda-cleared drug-delivery device, today announced it will host its second quarter 2025 financial results and business highlights conference call on august 14, 2025, at 4:30 p.m. et. additional details will be available in the investor relations section of the company's website at h.
RNXT Ratings Summary
RNXT Quant Ranking